Cancer Research News Updates
October 3, 2017
Radio-immunotherapy combination slows tumor growth A study from the MD Anderson Cancer Center has shown that a combination of stereotactic body radiation therapy (SBRT) and immunotherapy can halt the growth of tumors in patients with end-stage (Read More)
The Cancer Research Institute and Parker Institute for Cancer Immunotherapy Announce First Patients Treated in Pancreatic Cancer Clinical Trial Combining Immunotherapy and Chemotherapy. SAN FRANCISCO and NEW YORK – Sept. 20, 2017 – The Parker (Read More)
What is Thyroid Cancer?
September 29, 2017
Overview Thyroid cancer is a disease in which malignant cells are found in tissues of the thyroid gland. Your thyroid gland is a butterfly-shaped in your neck, at the base of your throat near your trachea (windpipe). It has two lobes, a left and (Read More)
Why is September Leukemia & Lymphoma Awareness Month?
September 27, 2017
Leukemia is cancer of the blood cells. In 2017, there are an estimated 363,794 people living with, or in remission from, leukemia in the US. Lymphoma is cancer that begins in infection-fighting cells of the immune system, called lymphocytes. In 2017, (Read More)
Why is September Leukemia & Lymphoma Awareness Month?
September 27, 2017
Leukemia is cancer of the blood cells. In 2017, there are an estimated 363,794 people living with, or in remission from, leukemia in the US. Lymphoma is cancer that begins in infection-fighting cells of the immune system, called lymphocytes. In 2017, (Read More)
FDA Approval Brings First Gene Therapy to United States
September 1, 2017
This week, The U.S. Food and Drug Administration issued a historic action making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases. The FDA (Read More)
Except for cervical cancer, for which there is the Pap Test, there are no tests or screenings to detect cancer, especially at an early stage, in other female organs. This includes ovarian cancer, uterine cancer, vaginal cancer and vulvar cancer. One (Read More)
Except for cervical cancer, for which there is the Pap Test, there are no tests or screenings to detect cancer, especially at an early stage, in other female organs. This includes ovarian cancer, uterine cancer, vaginal cancer and vulvar cancer. One (Read More)
OHC to Exclusively Offer Paxman Scalp Cooling to Help Prevent Hair Loss Caused by Certain Chemotherapy Drugs
August 16, 2017
The first question that people generally ask about chemotherapy is whether or not they will lose their hair. Many patients rank hair loss as their most feared and experienced side effect of chemotherapy treatment. The psychological effect is high and (Read More)
Here’s One Way to Help a Cancer Patient
August 11, 2017
Are you looking for some way to help a friend or family member who is getting chemotherapy? Consider making a gift bag for chemo patients. Our friends Karen Herzog and Pat West for Teal Loving Care recently donated 65 gift bags to patients at our OHC (Read More)
FDA Approves New Targeted Therapy for AML
August 9, 2017
Last week, news broke that the FDA had approved a new treatment for patients with acute myeloid leukemia (AML). I want to share the news from the Leukemia & Lymphoma Society (LLS) because it’s an exciting breakthrough for these patients. (Read More)
Life After Surviving Cancer
July 14, 2017
Surviving cancer is one of the greatest successes ever. More and more people are surviving thanks to new treatments, new technology and more information and focus on prevention. But once you are diagnosed with cancer, your life will change. Even (Read More)
When you first walk into the room, you’re struck by the size of the machine. It’s big, standing close to seven feet high. It’s also thick, and has a rounded, futuristic look to it. Yet, this thing seems a bit familiar, too. It looks like (Read More)
Why Is Diet Soda Bad for You?
June 15, 2017
Healthy eating involves making good choices each and every day—from food purchases to meal prep, ingredient subs to diligent recipe research. With so much time devoted to the process, it can be disheartening to discover that certain products that (Read More)
Orlando, FL — “Are we really measuring quality, or are we measuring our ability to report?” asked Brian R. Bourbeau, MBA, Director, Practice Operations, Oncology Hematology Care, the US Oncology Network, Cincinnati, OH. “So far it’s been (Read More)